Our study aimed to evaluating significance of survivin as a
prognostic marker of relapse in children with acute lymphoblastic
leukemia. The study included 46 child (30 males, 16 females): 24
child with ALL at 35 day from BFM 95 Protocol and 22 rel
apse
child with ALL.
Bladder cancer is the most common malignancy of the urinary
tract, and has the fastest rate of recurrence which gives it high
prevalence of tumors all over the world. Early diagnosis is very
important for treatment efficacy, prevent tumor progress
ion and
prolong survival period, so many urinary markers have been
studied but early diagnosis of carcinoma of bladder remains a
challenge. Survivin is a member of the inhibitor of apoptosis
protein family (IAPs), whose irregular expression is associated with
tumor cell proliferation, progression, angiogenesis, therapeutic
resistance, and poor prognosis.
